Receptor activator of nuclear factor κ-B (RANKL) activation induced by bone mineral disorder will promote calcification and osteogenic transdifferentiation of vascular smooth muscle cells [36]. The gene discussed is TNFSF11; the disease is abnormal mineralization disorder.